Overview
Typical nemaline myopathy (also called typical congenital nemaline myopathy or nemaline rod myopathy, typical form) is the most common form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This form primarily affects the skeletal muscular system and, in some cases, the respiratory system. It is classified under congenital myopathies (ICD-10: G71.2) and is distinguished from the severe neonatal and milder childhood-onset forms by its intermediate clinical presentation. Typical nemaline myopathy usually presents in infancy or early childhood with generalized muscle weakness that predominantly affects proximal muscles, the trunk, and facial muscles. Affected individuals commonly exhibit hypotonia (reduced muscle tone), delayed motor milestones, facial weakness with a characteristic elongated face, a high-arched palate, nasal speech, and feeding difficulties. Weakness tends to be more prominent in flexor muscles of the neck and limb-girdle muscles. Respiratory muscle involvement can occur and may lead to respiratory insufficiency, which is a significant source of morbidity. Deep tendon reflexes are often reduced or absent. Most individuals with typical nemaline myopathy achieve independent ambulation, though motor abilities may be limited, and the clinical course is generally non-progressive or slowly progressive. There is currently no cure or disease-specific treatment for typical nemaline myopathy. Management is supportive and multidisciplinary, including physical therapy to maintain mobility and prevent contractures, respiratory monitoring and support (including non-invasive ventilation when needed), nutritional support for feeding difficulties, orthopedic interventions for scoliosis or foot deformities, and speech therapy. Genetic counseling is recommended for affected families. Multiple genes have been implicated, including NEB (nebulin), ACTA1 (skeletal muscle alpha-actin), TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, and LMOD3, with mutations in NEB being the most common cause of the typical form.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Typical nemaline myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Typical nemaline myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Typical nemaline myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Typical nemaline myopathy.
Community
No community posts yet. Be the first to share your experience with Typical nemaline myopathy.
Start the conversation →Latest news about Typical nemaline myopathy
No recent news articles for Typical nemaline myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Typical nemaline myopathy
What is Typical nemaline myopathy?
Typical nemaline myopathy (also called typical congenital nemaline myopathy or nemaline rod myopathy, typical form) is the most common form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This form primarily affects the skeletal muscular system and, in some cases, the respiratory system. It is classified under congenital myopathies (ICD-10: G71.2) and is distinguished from the severe neonatal and milder childhood-onset forms by its intermediate clinical
At what age does Typical nemaline myopathy typically begin?
Typical onset of Typical nemaline myopathy is infantile. Age of onset can vary across affected individuals.